Clinical Trials Browser

Cervical Esophagus Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Gastroesophageal Adenocarcinoma

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Adenocarcinoma, Prostatic Neoplasms

Carcinoma, Transitional Cell

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Prostatic Neoplasms, Urethral Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

Prostatic Neoplasms

Adenocarcinoma

Breast Neoplasms

Prostatic Neoplasms

Prostate Cancer Metastatic

Head and Neck Neoplasms, Melanoma, Parotid Neoplasms, Thyroid Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Clinical Stage I Gastric Cancer AJCC v8

Prostatic Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Recurrence

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Prostatic Neoplasms

Unspecified Adult Solid Tumor, Protocol Specific

Advanced Breast Cancer

Urinary Bladder Neoplasms, Urethral Neoplasms

Unspecified Adult Solid Tumor, Protocol Specific

Breast Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma

Prostatic Neoplasms

Stomach Neoplasms

Head and Neck Neoplasms

Unspecified Adult Solid Tumor, Protocol Specific

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Lung Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer

MEDINDUCTION

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Lutécio

A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer

Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

I-FLOAT

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC

Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer

Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

DOP

Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer

CCODG-NSCLC

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

EDALINE

Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer

PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin

Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer

Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer

A Study of the Proper Dosage of Lovastatin and Docetaxel for Patients With Cancer

Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors